SEP 9, 2026 · PHASE 2 TRIAL
Study of TUB-040 in Participants With Unresectable or Metastatic Nonsquamous Non-small Cell Lung Cancer
ClinicalTrials.gov
This is a planned Phase 2 interventional trial with no results posted; it is in pre-recruitment stage and represents early-phase development of TUB-040 in NSCLC.
Reported
Planned enrollment80
PhasePhase 2
Primary outcome 1: Treatment-emer…Enrollment until 30 days after last dose